Moberg Pharma Q2: Teclara is the clear market leader in both Sweden and Norway - Redeye

Q2 confirms that Moberg’s Terclara is now the market leader in both Sweden and Norway. Consumer marketing activities and a strong channel presence have resulted in high market shares of 44% in Sweden (value) and 43% in Norway (value). The H1 2025 success is a good platform ahead of the expanded European Teclara launch in 2026.

Länk till analysen i sin helhet: https://www.redeye.se/research/1121805/moberg-pharma-q2-teclara-is-the-clear-market-leader-in-both-sweden-and-norway?utm_source=finwire&utm_medium=RSS